Showing results (641-650 of 6,994) with videos related to
Sort By:
Pageof 700
Cancer Science|April 12, 2011
Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cellsGianluca Baldanzi, Stefano Pietronave, Deborah Locarno, et al.Cancer Science|April 7, 2011
An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cellsChantal Garand, David Guay, Chris Sereduk, et al.Cancer Science|June 1, 2011
Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphomaMichinori Ogura, Kiyoshi Ando, Masafumi Taniwaki, et al.Cancer Science|May 19, 2011
Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 studyNoriko Usui, Akihiro Takeshita, Chiaki Nakaseko, et al.Cancer Science|May 19, 2011
Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patientsNiansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, et al.Cancer Science|June 4, 2011
Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transductionMi-Kyung Song, Youn-Jung Kim, Mee Song, et al.Cancer Science|April 27, 2011
Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytomaMasanobu Kano, Tomohide Tsukahara, Makoto Emori, et al.Cancer Science|April 27, 2011
Roles of Pim-3, a novel survival kinase, in tumorigenesisNaofumi Mukaida, Ying-Ying Wang, Ying-Yi LiCancer Science|May 5, 2011
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic markerMasashi Takawa, Ken Masuda, Masaki Kunizaki, et al.Cancer Science|May 28, 2011
Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinomaHye Won Chung, Jong-Baeck LimPageof 700